MC
ACER

Moors & Cabot’s Acer Therapeutics Inc ACER Stock Holding History

Moors & Cabot’s Portfolio ACER Stock Details ACER Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-156
Closed -$8K – 553
2015
Q1 		$8K Sell
156
-24
-13% -$1.47K ﹤0.01% 510
2014
Q4 		$9K Sell
180
-192
-52% -$13.9K ﹤0.01% 508
2014
Q3 		$31K Hold
372
– – 0.01% 531
2014
Q2 		$51K Buy
372
+180
+94% +$23.8K 0.01% 524
2014
Q1 		$30K Buy
+192
New +$29.1K 0.01% 374

Other funds holding ACER

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Creative Planning
Creative Planning Overland Park, Kansas $147B AUM 18.73% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Moors & Cabot's ACER Position: Q2 2015 in Review

Moors & Cabot sold out of Acer Therapeutics Inc (ACER) in Q2 2015, closing a stake of 156 shares — an estimated $8K sold.

Moors & Cabot first reported a position in ACER in Q1 2014 and held it in 5 quarters. The position peaked at $51K in Q2 2014. 16 funds tracked by Wall St. Rank hold ACER as of Q2 2015.

  • Moors & Cabot reported no remaining Acer Therapeutics Inc position as of Q2 2015 after selling out during the quarter.
  • Moors & Cabot sold 156 Acer Therapeutics Inc shares in Q2 2015, an estimated $8K.
  • Moors & Cabot first reported a position in Acer Therapeutics Inc in Q1 2014 and held it in 5 quarters.
  • Moors & Cabot's Acer Therapeutics Inc position peaked at $51K in Q2 2014.
  • 16 funds tracked by Wall St. Rank held Acer Therapeutics Inc as of Q2 2015.

Based on Moors & Cabot's 13F filing for Q2 2015, filed 17 Aug 2015.